These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38977593)

  • 1. α-Linolenic Acid Vesicles-Mediated Tau Internalization in Microglia.
    Chinnathambi S
    Methods Mol Biol; 2024; 2816():117-128. PubMed ID: 38977593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internalization and Endosomal Trafficking of Extracellular Tau in Microglia Improved by α-Linolenic Acid.
    Desale SE; Chidambaram H; Qureshi T; Chinnathambi S
    Methods Mol Biol; 2024; 2761():245-255. PubMed ID: 38427241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Linolenic Acid Induces Microglial Activation and Extracellular Tau Internalization.
    Desale SE; Chidambaram H; Chinnathambi S
    Methods Mol Biol; 2024; 2754():471-481. PubMed ID: 38512683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody.
    Luo W; Liu W; Hu X; Hanna M; Caravaca A; Paul SM
    Sci Rep; 2015 Jun; 5():11161. PubMed ID: 26057852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and Biophysical Characterization of Tau and α-Linolenic Acid Vesicles In Vitro.
    Desale SE; Chidambaram H; Chinnathambi S
    Methods Mol Biol; 2024; 2754():193-203. PubMed ID: 38512668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α- Linolenic acid modulates phagocytosis and endosomal pathways of extracellular Tau in microglia.
    Desale SE; Chinnathambi S
    Cell Adh Migr; 2021 Dec; 15(1):84-100. PubMed ID: 33724164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease.
    Hopp SC; Lin Y; Oakley D; Roe AD; DeVos SL; Hanlon D; Hyman BT
    J Neuroinflammation; 2018 Sep; 15(1):269. PubMed ID: 30227881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer's Disease.
    Nanjundaiah S; Chidambaram H; Chandrashekar M; Chinnathambi S
    Cell Mol Neurobiol; 2021 May; 41(4):651-668. PubMed ID: 32468440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Exosomes: Friend or Foe in Alzheimer's Disease?
    Kaur S; Verma H; Dhiman M; Tell G; Gigli GL; Janes F; Mantha AK
    Mol Neurobiol; 2021 Dec; 58(12):6610-6624. PubMed ID: 34595669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of microglia and inhibition of exosome synthesis halt tau propagation.
    Asai H; Ikezu S; Tsunoda S; Medalla M; Luebke J; Haydar T; Wolozin B; Butovsky O; Kügler S; Ikezu T
    Nat Neurosci; 2015 Nov; 18(11):1584-93. PubMed ID: 26436904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trem2 deletion enhances tau dispersion and pathology through microglia exosomes.
    Zhu B; Liu Y; Hwang S; Archuleta K; Huang H; Campos A; Murad R; Piña-Crespo J; Xu H; Huang TY
    Mol Neurodegener; 2022 Sep; 17(1):58. PubMed ID: 36056435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic Receptor P2Y12-Mediated Tau Internalization in Microglia.
    Chidambaram H; Desale SE; Chinnathambi S
    Methods Mol Biol; 2024; 2754():457-470. PubMed ID: 38512682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunctional microglia and tau pathology in Alzheimer's disease.
    Ayyubova G
    Rev Neurosci; 2023 Jun; 34(4):443-458. PubMed ID: 36302379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.
    Scholtzova H; Chianchiano P; Pan J; Sun Y; Goñi F; Mehta PD; Wisniewski T
    Acta Neuropathol Commun; 2014 Sep; 2():101. PubMed ID: 25178404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Serum Exosomes from a Transgenic Mouse Model of Alzheimer's Disease.
    Rosas-Hernandez H; Cuevas E; Raymick JB; Robinson BL; Ali SF; Hanig J; Sarkar S
    Curr Alzheimer Res; 2019; 16(5):388-395. PubMed ID: 30907317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease.
    Sun XY; Li LJ; Dong QX; Zhu J; Huang YR; Hou SJ; Yu XL; Liu RT
    J Neuroinflammation; 2021 Jun; 18(1):131. PubMed ID: 34116706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Linolenic acid inhibits Tau aggregation and modulates Tau conformation.
    Desale SE; Dubey T; Chinnathambi S
    Int J Biol Macromol; 2021 Jan; 166():687-693. PubMed ID: 33130263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.